This indicates UBE2S takes part in promoting endodermal metastasis and metastasis in pancreatic cancer cells in vitro and in vivo by inhibiting promoter activity in the VHL/HIF-1α/STAT3 pathway [63]. Here, UBE2S is linked to pancreatic neoplasm.